Stephanie Smith-Marrone, MD

Specialties:
Medical Oncology

More specialties
Accepting New Patients

Profile Navigation

Overview
Schedule an Appointment
Location(s)
Insurance Accepted
Credentials & Experience
Research

Overview

Stephanie Smith-Marrone, MD, is board certified in oncology and an assistant professor of medicine at Columbia University Medical Center. She is also the director of the lung cancer disease management team and clinical trials at NewYork-Presbyterian Lawrence Hospital Cancer Center. Dr. Smith-Marrone specializes in medical oncology, lung cancer, and head and neck cancer. She offers her patients a personalized, supportive, and collaborative-care approach and works to improve their health by using scientific advances and individualized treatment options. Dr. Smith-Marrone completed her medical degree, internship, residency and chief residency at Stony Brook University Medical Center in New York. She continued her training by serving a fellowship in hematology and oncology at Montefiore Medical Center.

Areas of Expertise / Conditions Treated

Head and Neck Cancer
Lung Cancer
Oral Cancer

Academic Appointments

Assistant Professor of Medicine at CUMC

Hospital Affiliations

NewYork-Presbyterian Westchester
NewYork-Presbyterian Westchester

Gender

Female

Schedule an Appointment

Phone Appointments

New and Existing Patients: (914) 787-3100

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.
Connect Sign In

Location(s)

NewYork-Presbyterian Westchester
55 Palmer Avenue

Bronxville, NY 10708

Primary

Phone: (914) 787-3100



Open location in Google Maps

Insurance Accepted

1199 National Benefit Fund

1199 National Benefit Fund

Aetna

Aetna

Affinity Health Plan

Affinity

Amida Care

Amida Care

Anthem Blue Cross Blue Shield

Anthem Blue Cross Blue Shield

Cigna

Cigna

Connecticare

Connecticare

Elderplan

Elderplan

Empire Blue Cross/Blue Shield

Empire Blue Cross Blue Shield

Fidelis Care

Fidelis Care

Healthfirst

Healthfirst

Multiplan

Multiplan

MVP Health Care

MVP Health Care

Unicare

Unicare

UnitedHealthcare

UnitedHealthcare

VNSNY CHOICE

VNSNY CHOICE

WellCare

WellCare

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

Medical Doctor (MD), New York Presbyterian Hospital
Residency: 2005 SUNY Stony Brook University Hospital
Fellowship: 2008 Albert Einstein College of Medicine

Board Certifications

Medical Oncology

Research

Dr. Smith-Marrone is currently the Director of Cancer Clinical Trials at NYP/Lawrence Hospital and also refers lung and head and neck cancer patients to clinical trials available through Herbert Irving Comprehensive Cancer Center at Columbia University.

Selected Publications

Susana Hernandez, Tiffany Negri, Adrian G. Sacher, Stephanie Smith-Marrone, Mark Stoopler, Justin F. Gainor, Mark M. Awad, Frank D'Ovidio, Joshua R. Sonett, Matthew Bacchetta, Anjali Saqi, Naiyer A. Rizvi; Columbia University Medical Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; Massachusetts General Hospital, Boston, MA; Massachusetts General Hospital, Cambridge, MA. "Neoadjuvant atezolizumab + chemotherapy in resectable non-small cell lung cancer (NSCLC)." J Clin Oncol 36, 2018 (suppl; abstr 8532)
M.C. Pietanza, MatthewD. Hellmann, John J. Fiore, Stephanie Smith-Marrone, Ethan M. Basch, Lawrence H. Schwartz, Michelle S. Ginsberg, Marwan Shouery, Samantha K. Newman, Mary Shaw, Lauren J. Rogak, Alex E. Lash, Patrick Hilden, Mark G. Kris, "Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas. J Thor Oncol. 2016; 11: 890-899.
Waldman, Abigail H., Jennifer M. Mcniff, Annmarie Liapakis, William S. Asch, Stephanie Smith-Marrone, and Oscar R. Colegio. Revision of Immunosuppression in a Solid Organ Transplant Recipient Leads to Complete Remission of Metastatic Undifferentiated Carcinoma." JAAD Case Reports 1.6 (2015): S8-S11.
Fury, M. G., Xiao, H., Sherman, E. J., Baxi, S., Smith-Marrone, S., Schupak, K., Gewanter, R., Gelblum, D., Haque, S., Schoder, H., Shah, J. P., Katabi, N., Kurtzman, R., Lipson, B., Cox, L., Lee, N. Y. and Pfister, D. G. (2015), Phase II trial of bevacizumab?+?cetuximab?+?cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma. Head Neck. doi: 10.1002/hed.24041
Gregory J. Riely, Helena Alexandra Yu, Dennis Stephens, Maria Catherine Pietanza, Stephanie Smith-Marrone, John Joseph Fiore, Melissa Goldstein, Camelia S. Sima, Mark G. Kris, and Michelle S. Ginsberg. A Phase I Study of Crizotinib and ganestespib (STA-9090) in ALK positive lung cancers. J Clin Oncol (Meeting Abstracts) May 2015 vol. 33 no. 15_suppl 8064.


For a complete list of publications, please visit PubMed.gov